J&J suffers knock-back in drug-eluting stent wars
This article was originally published in Clinica
Executive Summary
Johnson & Johnson was dealt a blow recently in its courtroom wrangling with rival heart stent makers Abbott, Boston Scientific and Medtronic over patents relating to the devices' drug coating.